AGP Executive Report
Last update: 24 minutes agoHealth Tech & Safety: A Liechtenstein-linked PR scam is making the rounds: fake “Forbes” sites (including “Forbes Liechtenstein”) are packed with paid promotional posts, with AI-written pieces and hard-to-trace bylines; Forbes says the sites are fake and is taking action. Global Health & Drugs: Gan & Lee’s weight-loss drug deal is a big one for Europe: Menarini has bought rights to commercialize Bofenglutide for overweight/obesity across EU states plus Switzerland, Norway, Iceland, Liechtenstein and more, with upfront and milestone payments and royalties. Climate & Public Health: July 2026 is tied with July 2024 as the hottest month on record, raising the stakes for heat-related health risks. Local Health Policy: Liechtenstein’s regent, Prince Alois, says he will block any move to legalise abortion beyond current limits, noting many women still travel abroad for care. Wellness Lifestyle: If you’re planning a healthier routine while traveling, Bulgaria’s new digital nomad visa is being pitched as an affordable base for hiking and longer stays.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.